Ruti Aga: A forged prescription and a six-year ban — the final lock on a marathon career

Ethiopian marathon runner Ruti Aga has been handed a six-year ban by the Athletics Integrity Unit (AIU). The sanction is built from two separate violations — two years for the presence of methylprednisolone in an in-competition sample and four years for tampering, after she submitted a forged prescription and gave misleading statements during the investigation. Six years in total. That arithmetic tells the whole story: Aga was not brought down by a steroid, but by the very document manufactured to defend her. A technical correction is essential here, because much of the coverage has framed this case wrongly. Methylprednisolone is not an anabolic steroid. It is a glucocorticoid, listed in class S9 of the WADA Prohibited List, not S1. Under the current List, S9 glucocorticoids are prohibited in-competition only, and only by injection, oral or rectal routes. The practical consequence: a therapeutic knee injection given out of competition is entirely legal. It becomes a violation only if residues are present in a sample taken in-competition — meaning the case turned not on the nature of the drug but on the route of administration and the timing relative to the race. That makes it wrong on both counts to present this as a 'steroid bust'. On the other side, Aga had a legitimate defence available: with genuine medical records and a coherent explanation of timing and route of administration, the matter could have been handled entirely within the framework of documented treatment and a Therapeutic Use Exemption. Instead she took a step that destroyed the one defence that could have worked. The AIU investigation found that the prescription Aga submitted for her knee injury was issued by a family member with no medical registration. That person claimed to have used 'an old prescription pad from a former workplace'. The clinic named on the document did not exist — and explicitly disowned it. Three independent verification failures at once. This was not a filing error. It was the signature of an athlete operating without a credentialed team physician and without any formal medical support structure. It matters that the four-year tampering sanction rests not only on the document but on an interview — statements made under questioning played a role. Language and translation conditions in AIU interviews with East African athletes have been a recurring point of contention, though it is not clear here how far Aga damaged herself through her own account. A technical detail is also worth spelling out: the testing window at a road race opens at 23:59 the day before the race. A glucocorticoid injection given days earlier, with residues still present, will be caught. A completely valid sports-medicine practice can become a violation purely through a timing error — the most ironic angle of this case. Seen through the lens of age, the ban is functionally a career end. Aga is 32. A six-year sanction starting 10 September would return her to competition at roughly 38. Given the depth of Ethiopian women's marathon running — world-record class athletes, multiple women running under 2:14 — selecting a 38-year-old with a doping record is close to impossible. On paper the ban is a fixed term; in practice it is a lifetime ban. Her record is not entirely erased. The 2026 Tokyo Marathon title and three second-place finishes at World Marathon Majors predate the violation. Absent evidence of earlier use, those results are not automatically annulled. It is, however, highly likely that the result and prize money from the Chinese half marathon at which the sample was collected will be voided — under standard AIU procedure, the competition where the sample is taken is automatically disqualified. Aga won that race in March, but no time, no splits and no field data appear in the reporting. No performance analysis is therefore possible; all that can be said is that it was a Label-tier race with in-competition testing. How was the six-year figure reached? The breakdown: two years for the presence violation — a prohibited substance in the body, classed as a Specified Substance, where the sanction is lower when intent is not proven — plus four years for tampering, the Code's standard sanction. The sum signals that the panel rejected the no-significant-fault mitigation. The moment Aga submitted the forged prescription, she closed off the route to that mitigation herself. The case is now part of a larger argument. A six-year ban for a glucocorticoid is a striking outcome, because the substance has no proven endurance benefit — it reduces pain and inflammation, it does not enhance performance. But the punishment is not for the drug; it is for document fraud. That is why the case has become a reference point both for those citing AIU rigour and for those alleging disproportionate enforcement against African road runners. There is a deeper structural question about the root cause. It is the knee injury. Chronic knee trouble is a known failure mode among marathoners. Injured runners face pressure to protect appearance fees and contracts, and glucocorticoids are the cheapest, most accessible tool for that. Without a proper medical support system, that cheap solution becomes a chain that leads to prescription forgery. The case therefore should not be read as one athlete's error but as a governance failure in the medical support around East African road running. Chinese Label races have become a high-scrutiny zone. Large appearance-fee budgets, deep East African elite fields and AIU testing presence all converge there. The economic system that made these races attractive is now generating the greatest integrity risk. Aga's case is the clearest illustration of that collision. Finally, is there any scope for appeal? The CAS window (typically around 21 days from the reasoned decision) remains open, but the forgery finding is document-based and extremely hard to overturn. The sharpest lesson is this: Aga's story has little evidence on the track and a great deal in the files. This is not an accident built from one injury, one injection and one lie; it is a portrait of a system in which a gifted runner had no clean route to prove her treatment — except one that was not legal.